Main > A1. CORP. INDEX. Mn-Mz > MorphoSys/P C2

---

This data is not available for free

MorphoSys/P C2's subsections
2000. 09.18.2000. (Roche AD Deal)
2002. 07.01.2002. (Roche AD Deal)
2003. 02.03.2003. (Combi Ab Deal)
2004. 08.23.2004. (Boehringer I.)
2006. 12.20.2006. (Pfizer)
2007. 10.08.2007. (Genesis R&D)
2007. 12.02.2007. (Novartis)
2007. 12.02.2007. (Roche MAb)
2007. 12.10.2007. (CEO)
2007. 12.10.2007. (GeneFrontier)
2008. 03.17.2008. (MOR202)
2008. 03.26.2008. (Daiichi Sankyo)
2008. 04.24.2008. (Leibniz-Institu)
2008. 08.18.2008. (MOR202)
2009. 10.20.2009. (Daiichi Sankyo)
2011. 12.15.2011. Novozymes
2012. 01.23.2012. Patent
2012. 02.27.2012. Slonomics Tech.
2012. 03.28.2012. Novartis
2012. 04.18.2012. SB Members
2012. 05.30.2012. Man. Appointments
2012. 05.31.2012. Supervisory Board
2012. 06.06.2012. Roche
2012. 12.06.2012. Patent
2013. 02.08.2013. Patent
2013. 06.03.2013. RA
2013. 09.19. Raises EUR 84M
2013. 12.03. Onco.>MOR208>Patent
2014. 04.29. Temple Uni.
2014. 10.15. Lanthipeptide Tech.
2019. 01.26. Onco.>Patents InValid
2024. 02.05. Acq. By Novartis
AbD Serotec Div. C2
Web-Site

MorphoSys/P C2's products
This section has no products